These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1908182)

  • 1. Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus.
    Pedersen O; Hother-Nielsen O; Bak J; Hjollund E; Beck-Nielsen H
    Am J Med; 1991 Jun; 90(6A):22S-28S. PubMed ID: 1908182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients.
    Bak JF; Schmitz O; Sørensen NS; Pedersen O
    Diabetes; 1989 Nov; 38(11):1343-50. PubMed ID: 2559864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliclazide and insulin action in human muscle.
    Bak JF; Pedersen O
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S61-4. PubMed ID: 1794267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
    Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
    Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy.
    Nyomba BL; Freymond D; Raz I; Stone K; Mott DM; Bogardus C
    Metabolism; 1990 Nov; 39(11):1204-10. PubMed ID: 2122177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
    Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
    J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte insulin binding and action in moderately obese NIDDM patients after dietary control of plasma glucose: reversal of postbinding abnormalities.
    Hjøllund E; Pedersen O; Sørensen NS
    Diabetes Care; 1987; 10(3):306-12. PubMed ID: 3595396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM.
    Sinha MK; Pories WJ; Flickinger EG; Meelheim D; Caro JF
    Diabetes; 1987 May; 36(5):620-5. PubMed ID: 3032715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin receptor function and glycogen synthase activity in human skeletal muscle. Physiology and pathophysiology.
    Bak JF
    Dan Med Bull; 1994 Apr; 41(2):179-92. PubMed ID: 8039433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antilipolytic effect of insulin in non-insulin-dependent diabetes mellitus after conventional treatment with diet and sulfonylurea.
    Bolinder J; Arner P
    Acta Med Scand; 1988; 224(5):451-9. PubMed ID: 3144155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance.
    Zierath JR; Galuska D; Nolte LA; Thörne A; Kristensen JS; Wallberg-Henriksson H
    Diabetologia; 1994 Mar; 37(3):270-7. PubMed ID: 8174841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mixed meal potentiates the insulin sensitivity of glucose transport and metabolism in adipocytes from patients with type 2 diabetes mellitus.
    Lange A; Bak J; Andersen PH; Richelsen B; Pedersen O
    Diabet Med; 1988 Nov; 5(8):761-5. PubMed ID: 2975568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glyburide on in vivo insulin-mediated glucose disposal.
    Simonson DC
    Am J Med; 1990 Aug; 89(2A):44S-50S; discussion 51S-53S. PubMed ID: 2117389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolic effects of gliclazide and glibenclamide in the rat.
    Musbah MO; Furman BL
    J Pharm Pharmacol; 1980 Aug; 32(8):550-3. PubMed ID: 6106691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptor binding and metabolic effects of insulin in human subcutaneous adipose tissue in untreated non-insulin dependent diabetes mellitus.
    Arner P; Engfeldt P; Skarfors E; Lithell H; Bolinder J
    Ups J Med Sci; 1987; 92(1):47-58. PubMed ID: 3296383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin-dependent diabetes mellitus: effects of physical training.
    Bak JF; Jacobsen UK; Jørgensen FS; Pedersen O
    J Clin Endocrinol Metab; 1989 Jul; 69(1):158-64. PubMed ID: 2499587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes.
    Pedersen O; Nielsen O; Bak J; Richelsen B; Beck-Nielsen H; Sørensen N
    Diabet Med; 1989 Apr; 6(3):249-56. PubMed ID: 2523787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.